Search research articles
Contact Us
Filters
Showing results (171-180 of 188) with videos related to
Page
of 19
Sort By:
Nature Reviews. Rheumatology
|
September 23, 2017
Synovial tissue research: a state-of-the-art review
Carl Orr, Elsa Vieira-Sousa, David L Boyle, et al.
Nature Reviews. Rheumatology
|
December 20, 2017
Corrigendum: Synovial tissue research: a state-of-the-art review
Carl Orr, Elsa Vieira-Sousa, David L Boyle, et al.
Journal of the National Cancer Institute
|
August 12, 2025
Childhood Cancer Data Initiative: Expanded access to tumor molecular profiling for children, adolescents, and young adults
Joseph Flores-Toro, Subhashini Jagu, Malcolm Smith, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 6, 2022
Paediatric Strategy Forum for medicinal product development in mitogen-activated protein kinase pathway inhibitors: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
Andrew Dj Pearson, Carl Allen, Jason Fangusaro, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 29, 2020
Paediatric Strategy Forum for medicinal product development of epigenetic modifiers for children: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
Andrew Dj Pearson, Kimberly Stegmaier, Franck Bourdeaut, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 8, 2014
Toward a drug development path that targets metastatic progression in osteosarcoma
Chand Khanna, Timothy M Fan, Richard Gorlick, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 27, 2024
Paediatric strategy forum for medicinal product development of PI3-K, mTOR, AKT and GSK3β inhibitors in children and adolescents with cancer
Andrew Dj Pearson, Steven G DuBois, Margaret E Macy, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 13, 2023
Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
Andrew D J Pearson, Sara Federico, Susanne A Gatz, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 18, 2021
Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies: ACCELERATE in collaboration with the European Medicines Agency with the participation of the Food and Drug Administration
Andrew D J Pearson, Elly Barry, Yael P Mossé, et al.
The Lancet. Oncology
|
June 2, 2019
Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial
Jason Fangusaro, Arzu Onar-Thomas, Tina Young Poussaint, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 188) with videos related to
Sort By:
Page
of 19
Nature Reviews. Rheumatology
|
September 23, 2017
Synovial tissue research: a state-of-the-art review
Carl Orr, Elsa Vieira-Sousa, David L Boyle, et al.
Nature Reviews. Rheumatology
|
December 20, 2017
Corrigendum: Synovial tissue research: a state-of-the-art review
Carl Orr, Elsa Vieira-Sousa, David L Boyle, et al.
Journal of the National Cancer Institute
|
August 12, 2025
Childhood Cancer Data Initiative: Expanded access to tumor molecular profiling for children, adolescents, and young adults
Joseph Flores-Toro, Subhashini Jagu, Malcolm Smith, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 6, 2022
Paediatric Strategy Forum for medicinal product development in mitogen-activated protein kinase pathway inhibitors: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
Andrew Dj Pearson, Carl Allen, Jason Fangusaro, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 29, 2020
Paediatric Strategy Forum for medicinal product development of epigenetic modifiers for children: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
Andrew Dj Pearson, Kimberly Stegmaier, Franck Bourdeaut, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 8, 2014
Toward a drug development path that targets metastatic progression in osteosarcoma
Chand Khanna, Timothy M Fan, Richard Gorlick, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 27, 2024
Paediatric strategy forum for medicinal product development of PI3-K, mTOR, AKT and GSK3β inhibitors in children and adolescents with cancer
Andrew Dj Pearson, Steven G DuBois, Margaret E Macy, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 13, 2023
Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
Andrew D J Pearson, Sara Federico, Susanne A Gatz, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 18, 2021
Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies: ACCELERATE in collaboration with the European Medicines Agency with the participation of the Food and Drug Administration
Andrew D J Pearson, Elly Barry, Yael P Mossé, et al.
The Lancet. Oncology
|
June 2, 2019
Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial
Jason Fangusaro, Arzu Onar-Thomas, Tina Young Poussaint, et al.
Page
of 19